Provided are ophthalmic pharmaceutical compositions comprising gallium. These compositions are designed primarily for topical ocular and intraocular administration. Also provided are methods of use for the compositions in the treatment of human and veterinary diseases and disorders. Treatable diseases and disorders include adverse conditions of the eye and adnexal tissues of the eye. These adverse conditions comprise inflammatory conditions, infections, cancers, and other pathological conditions.

 
Web www.patentalert.com

< Colloidal formulation of long-acting insulin and its preparation

> Methods and Compositions Related to Regulation of Cytokine Production by Glycogen Synthase Kinase 3 (Gsk-3)

~ 00449